-
Markets
-
Aktien
Sustainable finance2025 Euronext ESG Trends ReportWeiterlesenA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesWeiterlesenThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeWeiterlesenInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondWeiterlesenFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesWeiterlesenTrade mini bond futures on main European government bonds
-
Rohstoffe
- Übersicht
- Kurse überblick
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesWeiterlesenEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameWeiterlesenJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 23 Oct 2025 10:35 CEST |
PCI BIOTECH HOLDING | PCI Biotech update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2025 15:36 CEST |
PCI BIOTECH HOLDING | PCI Biotech update on future operations | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Aug 2025 07:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech half-year interim 2025 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 26 Aug 2025 16:14 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to first half 2025 results presentation and corporate update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Aug 2025 14:15 CEST |
PCI BIOTECH HOLDING | Flaggemelding | 20103010 Biotechnology | Major shareholding notifications |
| 22 Aug 2025 11:09 CEST |
PCI BIOTECH HOLDING | Flaggemelding | 20103010 Biotechnology | Major shareholding notifications |
| 18 Aug 2025 20:39 CEST |
PCI BIOTECH HOLDING | PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations | 20103010 Biotechnology | Inside information |
| 22 May 2025 11:45 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Minutes of Annual General Meeting 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2025 22:08 CEST |
PCI BIOTECH HOLDING | PCI BIotech: Disclosure of voting rights for Chair of the Board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 10:00 CEST |
PCI BIOTECH HOLDING | Notice of Annual General Meeting 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Apr 2025 17:30 CEST |
PCI BIOTECH HOLDING | PCI Biotech Holding ASA: Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 27 Feb 2025 07:00 CET |
PCI BIOTECH HOLDING | PCI Biotech full year 2024 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 25 Feb 2025 08:56 CET |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to preliminary full-year 2024 results presentation | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 10 Jan 2025 10:24 CET |
PCI BIOTECH HOLDING | PCI Biotech: Employee share option scheme in connection with promotion of new CSO | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 31 Oct 2024 16:33 CET |
PCI BIOTECH HOLDING | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Sep 2024 08:57 CEST |
PCI BIOTECH HOLDING | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Sep 2024 07:53 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Employee share option scheme | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 28 Aug 2024 07:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech first half 2024 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 23 Aug 2024 09:35 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to first half interim 2024 results presentation | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 24 May 2024 12:30 CEST |
PCI BIOTECH HOLDING | Minutes of Annual General Meeting 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2024 09:03 CEST |
PCI BIOTECH HOLDING | Disclosure of voting rights for Chair of the Board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2024 10:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech Holding ASA - Notice of Annual General Meeting 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Apr 2024 08:08 CEST |
PCI BIOTECH HOLDING | PCI Biotech Holding ASA - Annual Report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 14 Feb 2024 07:00 CET |
PCI BIOTECH HOLDING | PCI Biotech second half 2023 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 12 Feb 2024 09:26 CET |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to second half interim 2023 results presentation | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 13 Oct 2023 10:17 CEST |
PCI BIOTECH HOLDING | PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing | 20103010 Biotechnology | Inside information |
| 07 Sep 2023 12:36 CEST |
PCI BIOTECH HOLDING | PCI Biotech: European patent for mRNA delivery with fimaNAc | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Sep 2023 10:13 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Employee share option scheme | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 01 Sep 2023 11:04 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Write-down of share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 31 Aug 2023 10:25 CEST |
PCI BIOTECH HOLDING | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Aug 2023 07:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech first half 2023 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 25 Aug 2023 14:30 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to first half interim 2023 results presentation | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 25 May 2023 11:38 CEST |
PCI BIOTECH HOLDING | Minutes from Annual General Meeting 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2023 10:43 CEST |
PCI BIOTECH HOLDING | Disclosure of voting rights for Chairman of the Board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 May 2023 07:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech interim Q1 2023 results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 May 2023 15:52 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to Q1 2023 results presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 May 2023 10:04 CEST |
PCI BIOTECH HOLDING | PCI Biotech - Notice of Annual General Meeting 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 10:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech Holding ASA: Annual Report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 17 Feb 2023 07:00 CET |
PCI BIOTECH HOLDING | PCI Biotech interim Q4 2022 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 13 Feb 2023 15:35 CET |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to Q4 2022 results presentation | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 20 Jan 2023 12:37 CET |
PCI BIOTECH HOLDING | Flaggemelding relatert til PCIB | 20103010 Biotechnology | Major shareholding notifications |
| 20 Jan 2023 10:13 CET |
PCI BIOTECH HOLDING | Flagging | 20103010 Biotechnology | Flagging |